Zulresso
Drug Psychiatry/Psychology
NDC 72152-547-20
General payments
$213,916
Research payments
$1,681,599
Through program year 2025, $213,916 in general payments and $1,681,599 in research payments were reported against Zulresso (Psychiatry/Psychology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $11,992 | 32 |
| 2025 | Research | $138,494 | 3 |
| 2024 | General | $81,253 | 21 |
| 2024 | Research | $636,572 | 6 |
| 2023 | General | $12,302 | 642 |
| 2023 | Research | $781,684 | 7 |
| 2021 | General | $4,185 | 1 |
| 2019 | General | $104,183 | 421 |
| 2019 | Research | $124,848 | 2 |
Breakdown
The top 5 of 28 recipients; each share is of general payments naming this product in 2025.
The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 9 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,117 general · 18 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.